Faced with delisting, TCM firm tries to survive EU ban (2)

LIMITED INFLUENCE
Thorny as it is for these Chinese products to be removed from the EU market, the potential economic loss for Chinese firms delisting may be minimal since the primary markets for traditional Chinese medicine are the Chinese domestic and the Southeast Asian markets.
Traditional Chinese medicines recorded an export volume of 1.944 billion U.S. dollars in 2010.
However, some experts worry that the potential delisting of the traditional Chinese medicine may lead to the unemployment of many traditional Chinese medicine practitioners in EU countries and European patients relying on traditional Chinese medicine will face a drug shortage.